Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Happiest Baby, Inc. SNOO Postmarket Surveillance Study

NCT: NCT06361303 · RECRUITING

NCT IDNCT06361303
StatusRECRUITING
Start Date2023-11-29
Completion2028-04-30
SponsorHappiest Baby, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

Frequently Asked Questions

What is The Happiest Baby, Inc. SNOO Postmarket Surveillance Study?

The Happiest Baby, Inc. SNOO Postmarket Surveillance Study is a clinical trial registered under NCT06361303. Current status: RECRUITING.

What is the status of NCT06361303?

The current status of NCT06361303 (The Happiest Baby, Inc. SNOO Postmarket Surveillance Study) is: RECRUITING.

When did The Happiest Baby, Inc. SNOO Postmarket Surveillance Study start?

The Happiest Baby, Inc. SNOO Postmarket Surveillance Study started on 2023-11-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.